These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 29433132)

  • 1. [The economic value of vaccinations: a systematic review of Italian economic evaluations and HTA reports].
    Di Nardo F; Boccalini S; Calabrò GE; Marcellusi A; Ruggeri M; Bonanni P; Vitali R; Capannini E; Mennini FS; Cicchetti A; Panatto D; Gasparini R; Ricciardi W; De Waure C
    Ig Sanita Pubbl; 2017; 73(5):453-471. PubMed ID: 29433132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project.
    Gasparini R; Mennini FS; Panatto D; Bonanni P; Bechini A; Ricciardi W; DE Waure C; Marcellusi A; Cicchetti A; Ruggeri M; Boccalini S
    J Prev Med Hyg; 2015; 56(4):E150-4. PubMed ID: 26900329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella.
    Doggen K; van Hoek AJ; Luyten J
    Pharmacoeconomics; 2023 May; 41(5):481-497. PubMed ID: 36809673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methodological aspects of clinical and economic impact of vaccine interventions and HTA. Focus on HPV vaccination].
    Ricciardi W; Dirodi B; Bonanni P; Capri S; Castiglia P; Gabutti G; Gasparini R; Giorgi Rossi P; Grilli G; La Torre G
    Ann Ig; 2011; 23(5):419-34. PubMed ID: 22403995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment.
    Calabrò GE; Boccalini S; Panatto D; Rizzo C; Di Pietro ML; Abreha FM; Ajelli M; Amicizia D; Bechini A; Giacchetta I; Lai PL; Merler S; Primieri C; Trentini F; Violi S; Bonanni P; de Waure C
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012.
    Cortés I; Pérez-Camarero S; Del Llano J; Peña LM; Hidalgo-Vega A
    Vaccine; 2013 Aug; 31(35):3473-84. PubMed ID: 23764534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance for future HTA applications to vaccines: the HPV lesson.
    La Torre G; de Waure C; Chiaradia G; Mannocci A; Capri S; Bamfi F; Ricciardi W
    Hum Vaccin; 2011 Sep; 7(9):900-4. PubMed ID: 21865880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Wong CKH; Liao Q; Guo VYW; Xin Y; Lam CLK
    Vaccine; 2017 May; 35(24):3153-3161. PubMed ID: 28476628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the costs and benefits of pneumococcal vaccination in adults.
    Porchia BR; Bonanni P; Bechini A; Bonaccorsi G; Boccalini S
    Expert Rev Vaccines; 2017 Feb; 16(2):93-107. PubMed ID: 27680425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
    De Waure C; Sisti LG; Poscia A; Ricciardi W
    Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making?
    Pan XF; Griffiths UK; Pennington M; Yu H; Jit M
    Vaccine; 2015 Nov; 33(46):6164-72. PubMed ID: 26435189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptake.
    Uzochukwu BSC; Okeke C; Shuaib F; Torres-Rueda S; Vassall A; Jit M; Nonvignon J; Uzochukwu AC; Ruiz F
    Health Res Policy Syst; 2024 Jun; 22(1):73. PubMed ID: 38926716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review.
    Farah L; Davaze-Schneider J; Martin T; Nguyen P; Borget I; Martelli N
    Artif Intell Med; 2023 Jun; 140():102547. PubMed ID: 37210155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Evaluation of Medically Assisted Reproduction: A Methodological Systematic Review.
    Van Muylder A; D'Hooghe T; Luyten J
    Med Decis Making; 2023; 43(7-8):973-991. PubMed ID: 37621143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and effectiveness of influenza vaccination: a systematic review.
    D'Angiolella LS; Lafranconi A; Cortesi PA; Rota S; Cesana G; Mantovani LG
    Ann Ist Super Sanita; 2018; 54(1):49-57. PubMed ID: 29616674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against HPV virus: a systematic review of economic evaluation studies for developed countries.
    Kostaras D; Karampli E; Athanasakis K
    Expert Rev Pharmacoecon Outcomes Res; 2019 Apr; 19(2):147-158. PubMed ID: 30501434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of vaccines in Canada: A systematic review.
    Chit A; Lee JK; Shim M; Nguyen VH; Grootendorst P; Wu J; Van Exan R; Langley JM
    Hum Vaccin Immunother; 2016 May; 12(5):1257-64. PubMed ID: 26890128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].
    Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA
    Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.
    Welte R; Trotter CL; Edmunds WJ; Postma MJ; Beutels P
    Pharmacoeconomics; 2005; 23(9):855-74. PubMed ID: 16153131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.